Airon Technology's 2026 interim report shows revenue up 42%, net loss widens

Earnings
โดย 蓝鲸财经·CN·Read original
Summary · why it matters

Airon Technology released its 2026 interim report, with operating revenue of 186 million yuan, up 42.23% year on year, but net loss attributable to the parent widened to negative 14 million yuan, compared with negative 8 million yuan in the same period last year. Non-GAAP net profit was negative 13 million yuan, a narrower loss than the same period last year; net cash flow from operating activities was negative 45 million yuan, swinging from a net inflow in the same period last year to a substantial net outflow. The company said revenue growth was mainly driven by a recovery in the automated pharmacy market, stronger performance in traditional Chinese medicine intelligent and pharmaceutical information product lines, and expansion of overseas projects, but increased share-based payment amortization, reduced government subsidies, and a 39.86% year-on-year surge in administrative expenses put pressure on profitability.

Impact on stocks 1

Others · 1 stocks